Detailed Profile of Cerecor Inc. portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.
meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor,
He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Dr. Cerecor's president and chief executive Uli Hacksell announced his immediate retirement from those roles, saying that with the new $45 million deal and recent $5 million fundraising, "I can be Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.. The largest trade Uli's ever made was exercising 52,771 units of Cerecor Inc stock on 13 August 2013 worth over $56,993.
Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. 2017-08-14 · neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Chief Executive Officer. Cerecor seeks to initiate a Phase 1b/2a proof-of-concept study of CERC-007 in ASOD and MM patients in 2020.
This page shows the track record and history of Hacksell Uli insider trades in Cerecor Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI").
Cerecor Inc. , a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Chief Executive Officer.
Lecturer: Margareta Hammarlund-Udenaes, Faculty of Pharmacy; Uli Hacksell, Cerecor Inc., USA; Jens Juul Holst, Department of Biomedical
Uli Hacksell. Cerecor Inc. 2017 - Present.
Aug 14, 2017 Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business
20 okt 2020 Shareholders of SynAct Pharma proposes Uli Hacksell as new board ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra.
Print services
It is illegal for insiders to make trades in their companies based on specific, non-public information.
Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018.
Michaela bergeson
f skatt bokforing
förmedla budskap engelska
cad ltc
the utbildning jurist paragal
jan nordlander fränsta
skicka paket posten pris
Board of directors · Dr. Wenche Rolfsen Marlene Forsell Prof. Uli Hacksell Dr. Lennart Hansson Dr Yilmaz Mahshid.
Cerecor said it is selling the rights to its oral kappa opioid receptor antagonist CERC-501. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $83,600 and over the last 17 years Uli sold CERC stock worth over $0. Uli Hacksell CERC stock SEC Form 4 insiders trading Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Cerecor Inc. Names Uli Hacksell, Chairman of Cerecor and Former CEO of ACADIA, as President and CEO BALTIMORE--(BUSINESS WIRE)-- Cerecor Inc. ( CERC ) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Cerecor's president and chief executive Uli Hacksell announced his immediate retirement from those roles, saying that with the new $45 million deal and recent $5 million fundraising, "I can be Dr. Uli Hacksell’s total compensation package for 2016 was valued at $1.7 million, compared to the $1.1 million package received by Cerecor’s former President and Chief Executive Blake Paterson in 2015.
2016-05-20 · Uli Hacksell. President and Chief Executive Officer. Cerecor Inc. 400 E. Pratt Street. Suite 606. Baltimore, Maryland (410) 522-8707 (Name, address, including zip code, and telephone number, including area code, of agent for service) With copies to: Brent B. Siler. Cooley LLP. 1299 Pennsylvania Avenue, NW, Suite 700. Washington, DC 20004 (202
Styrelseledamot sedan 2019. Tidigare befattningar: VD för ACADIA Pharmaceuticals; VD och styrelseordförande i Cerecor Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. samt styrelseledamot i Beactica AB, Cerecor Inc, InDex Pharmaceuticals AB Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. Att stämman beslutar Därefter har han varit vd för Cerecor och Medivir. 09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. AB, Cerecor Inc, InDex Pharmaceuticals AB och Uppsala universitet.
Annotate, download XLSX & look up similar tables 2016-05-20 2016-05-20 2016-09-30 Cerecor stock soars 17% premarket after FDA grants fast-track designation to treatment for rare disorder.